BSE filing, NSE: SJS. Summary written from the filing by ALFA Finder's alert engine.
SJS Enterprises Ltd: key numbers
- Share price
- ₹2,046.80
- Market cap
- ₹6,601 Cr
- Revenue (annual)
- ₹955.1 Cr
- Net profit (annual)
- ₹170.7 Cr
- P/E (TTM)
- 31.4×Sector 30.9×
- Promoter holding
- 19.99%-0.16% QoQ
- FII holding
- 16.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SJS Enterprises Ltd
All →SJS Enterprises Board Meeting Date
S.J.S. Enterprises schedules a 4 November 2026 board meeting to approve unaudited quarterly results for September 2026. An earnings call follows on 5 November.
SJS Enterprises Other Announcement
S.J.S. Enterprises Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
SJS Enterprises Capacity Expansion: ₹81 Cr Investment
S.J.S. Enterprises' subsidiary, SDEPL, will invest ₹81 Crore to establish a new manufacturing facility in Pune. The project is expected to be completed by September 2027.
- Value
- ₹81.00 Cr
- Execution
- September 2027
- built-up manufacturing area
- 60000.0 sq. ft.
SJS Enterprises Capacity Expansion: ₹49 Cr Investment
S.J.S. Enterprises' subsidiary, Walter Pack, will invest ₹49 Crore to consolidate three manufacturing plants into a single, larger facility in Pune by May 2027.
- Value
- ₹49.00 Cr
- Execution
- May 2027
- net built-up area addition
- 63086.0 Sq Ft
SJS Enterprises Capacity Expansion: ₹45 Cr Investment
S.J.S. Enterprises is expanding its Bengaluru facility capacity by 20% to meet demand. The Rs. 45 crore investment will see production commence in Q3 FY27.
- Value
- ₹45.00 Cr
- capacity expansion
- 20.0 %
SJS Enterprises Merger & Restructuring Worth ₹5 Cr
S.J.S. Enterprises invested ₹5 Crore in its wholly owned subsidiary SDEPL via a rights issue, consistent with previously approved investment limits.
- Value
- ₹5.00 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date